Skip to content

Clinical trials

Phase 2 Phobia, Social trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Phobia, Social Phase: Phase 2 Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20043
20052
20062
20081
20101
20121
20152
20211
20223
20232
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
NYU Langone Health2
Avera Pharmaceuticals1
Bionomics Limited1
Duke University1
Eli Lilly and Company1
EmpowerPharm Inc.1
Engrail Therapeutics INC1
Georgia State University1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Phobia, Social23
Anxiety Disorders6
Phobic Disorders5
Generalized Anxiety Disorder3
Anxiety, Separation2
Mental Disorders2
Alcoholism1
Panic Disorder1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.